Skip to main content
. 2017 Dec;187(12):2895–2911. doi: 10.1016/j.ajpath.2017.08.006

Figure 2.

Figure 2

Association of plasma CXCL5 levels with lipids, cell counts, and statin use. A: Pairwise association analysis of the indicated variables summarized by the regression line and means (95% CIs). The correlation coefficient for each association is indicated and colored to reflect the P value. B–D: CXCL5 levels represented by dot plot and summarized by the means and 95% CIs of the log values. B: CXCL5 levels stratified by obstructive CAD status and statin use. C: CXCL5 levels stratified by statin type; the P value from one-way analysis of variance is indicated. D: CXCL5 levels stratified by statin intensity; the P value from one-way analysis of variance is indicated. ∗∗P < 0.01 for statin use with CXCL5 levels (t-test); †P < 0.05, ††P < 0.01 versus rosuvastatin (Tukey post-test). CAD, coronary artery disease; CHOL, cholesterol; HDL, high-density lipoprotein; LDL, low-density lipoprotein; N, no; PC, platelet counts; TG, triglyceride; WBC, white blood cell; Y, yes.